Home Tools
Log in
Cart

NecroX-7

Catalog No. T9948   CAS 1120332-55-9
Synonyms: LC-280126, LC28-0126, LC28 0126

NecroX-7 (LC-280126) is a potent free radical scavenger and a HMGB1 (high-mobility group box 1) inhibitor. NecroX-7 can be used as an antidote to acetaminophen toxicity. NecroX-7 exerts a protective effect by preventing the release of HMGB1 in ischemia/reperfusion injury. Additionally, NecroX-7 inhibits the HMGB1-induced release of TNF and IL-6, as well as the expression of TLR-4 and receptor for advanced glycation end products. NecroX-7 may be use for treatment of graft-versus-host disease (GVHD) research [1].

All products from TargetMol are for Research Use Only. Not for Human or Veterinary or Therapeutic Use.
NecroX-7 Chemical Structure
NecroX-7, CAS 1120332-55-9
Pack Size Availability Price/USD Quantity
1 mg In stock $ 51.00
5 mg In stock $ 122.00
10 mg In stock $ 198.00
25 mg In stock Inquiry
50 mg In stock Inquiry
Bulk Inquiry
Get quote
Select Batch  
Purity: 98.08%
Contact us for more batch information
Biological Description
Chemical Properties
Storage & Solubility Information
Description NecroX-7 (LC-280126) is a potent free radical scavenger and a HMGB1 (high-mobility group box 1) inhibitor. NecroX-7 can be used as an antidote to acetaminophen toxicity. NecroX-7 exerts a protective effect by preventing the release of HMGB1 in ischemia/reperfusion injury. Additionally, NecroX-7 inhibits the HMGB1-induced release of TNF and IL-6, as well as the expression of TLR-4 and receptor for advanced glycation end products. NecroX-7 may be use for treatment of graft-versus-host disease (GVHD) research [1].
In vitro NecroX-7, at concentrations ranging from 0 to 40 μM and incubated for 3-4 days, effectively suppresses the activation and proliferation of T cells without inducing apoptosis, as demonstrated in a study [1]. Additionally, this compound significantly reduces high-mobility group box 1 (HMGB1) levels in a dose-dependent manner and inhibits the generation of mitochondria-specific reactive oxygen species (ROS) and reactive nitrogen species in H9C2 cardiac cells and hepatocytes, triggered by tert-butyl hydroperoxide or doxorubicin [1]. Moreover, NecroX-7 has been shown to increase the numbers of regulatory T cells, suggesting its potential role in the modulation of differentiation signals that are independent of HMGB1 effects [1]. In a cell proliferation assay utilizing CD4 T cells across a gradient of 0 to 40 μM concentrations over 3-4 days, a significant decline in splenocyte proliferation was observed, indicating its effectiveness in modulating alloreactive T cell responses in a dose-dependant manner [1].
In vivo NecroX-7 (0-0.3 mg/kg, IV, once injection at 2-day intervals for 2 weeks) significantly reduces graft-versus-host disease (GVHD)-related mortality and severe tissue damage. It offers protection in mice against lethal GVHD through the reciprocal regulation of regulatory T/Th1 cells, reduces systemic High Mobility Group Box 1 (HMGB1) levels, and mitigates HMGB1-mediated inflammation. In an animal model involving female BALB/c and C57BL/6 mice (eight-week-old, with GVHD), dosages of 0.03, 0.1, and 0.3 mg/kg administered intravenously at two-day intervals for two weeks resulted in notable improvements. Statistically significant increases in survival rates were observed with doses ≥0.1 mg/kg, where 30–60% of treated mice survived for over 50 days. Additionally, treated mice exhibited significantly fewer clinical signs of acute GVHD, including reductions in weight loss, hunched posture, diarrhea, and ruffled fur, indicating an overall improvement in health and extended survival.
Synonyms LC-280126, LC28-0126, LC28 0126
Molecular Weight 439.57
Formula C24H29N3O3S
CAS No. 1120332-55-9

Storage

keep away from direct sunlight,store at low temperature

Powder: -20°C for 3 years | In solvent: -80°C for 1 year

TargetMolReferences and Literature

1. Grootaert MOJ, et al. NecroX-7 reduces necrotic core formation in atherosclerotic plaques of Apoe knockout mice. Atherosclerosis. 2016 Sep;252:166-174. 2. Park J, et al. NecroX-7 prevents oxidative stress-induced cardiomyopathy by inhibition of NADPH oxidase activity in rats. Toxicol Appl Pharmacol. 2012 Aug 15;263(1):1-6.

Related Products

Related compounds with same targets
Sprengerinin C Pisatin APX-115 free base Setanaxib Ketoconazole Zederone Cycloheterophyllin Cistanoside F

TargetMolDose Conversion

You can also refer to dose conversion for different animals. More

TargetMol In vivo Formulation Calculator (Clear solution)

Step One: Enter information below
Dosage
mg/kg
Average weight of animals
g
Dosing volume per animal
ul
Number of animals
Step Two: Enter the in vivo formulation
% DMSO
%
% Tween 80
% ddH2O
Calculate Reset

TargetMolCalculator

Molarity Calculator
Dilution Calculator
Reconstitution Calculation
Molecular Weight Calculator
=
X
X

Molarity Calculator allows you to calculate the

  • Mass of a compound required to prepare a solution of known volume and concentration
  • Volume of solution required to dissolve a compound of known mass to a desired concentration
  • Concentration of a solution resulting from a known mass of compound in a specific volume
See Example

An example of a molarity calculation using the molarity calculator
What is the mass of compound required to make a 10 mM stock solution in 10 ml of water given that the molecular weight of the compound is 197.13 g/mol?
Enter 197.13 into the Molecular Weight (MW) box
Enter 10 into the Concentration box and select the correct unit (millimolar)
Enter 10 into the Volume box and select the correct unit (milliliter)
Press calculate
The answer of 19.713 mg appears in the Mass box

X
=
X

Calculator the dilution required to prepare a stock solution

Calculate the dilution required to prepare a stock solution
The dilution calculator is a useful tool which allows you to calculate how to dilute a stock solution of known concentration. Enter C1, C2 & V2 to calculate V1.

See Example

An example of a dilution calculation using the Tocris dilution calculator
What volume of a given 10 mM stock solution is required to make 20ml of a 50 μM solution?
Using the equation C1V1 = C2V2, where C1=10 mM, C2=50 μM, V2=20 ml and V1 is the unknown:
Enter 10 into the Concentration (start) box and select the correct unit (millimolar)
Enter 50 into the Concentration (final) box and select the correct unit (micromolar)
Enter 20 into the Volume (final) box and select the correct unit (milliliter)
Press calculate
The answer of 100 microliter (0.1 ml) appears in the Volume (start) box

=
/

Calculate the volume of solvent required to reconstitute your vial.

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial.
Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

g/mol

Enter the chemical formula of a compound to calculate its molar mass and elemental composition

Tip: Chemical formula is case sensitive: C10H16N2O2 c10h16n2o2

Instructions to calculate molar mass (molecular weight) of a chemical compound:
To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.
Definitions of molecular mass, molecular weight, molar mass and molar weight:
Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed n the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.

bottom

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.

Keywords

NecroX-7 1120332-55-9 Immunology/Inflammation NADPH-oxidase LC 280126 NecroX7 LC-280126 NecroX 7 LC28-0126 LC280126 LC28 0126 inhibitor inhibit

 

TargetMol